CALGARY,
AB AND MOUNTAIN VIEW,
Calif, Nov. 7, 2022 /PRNewswire/ - Willow
Biosciences Inc. ("Willow" or the "Company")
(TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company
focused on revolutionizing industrial manufacturing of pure,
consistent, and sustainable functional ingredients, today announced
that it will host a webcast investor presentation on Thursday, November 10th at 2:00 PM EST.
During the webcast, Dr. Peter Seufer-Wasserthal, Willow's
President and Chief Executive Officer and Troy Talkkari, Vice President of Corporate
Development will provide a presentation that will cover key areas
of Willow's business. After the formal presentation, investors will
have an opportunity to ask relevant questions through an
interactive Q&A portal.
To listen to the webcast or to ask questions during the live
event, please pre-register at the following link:
https://event.webcasts.com/starthere.jsp?ei=1576448&tp_key=c06ce0c9af
An archived version of the webcast and presentation will be
available on the Company's website,
www.willowbio.com/#investors.
About Willow Biosciences Inc.
Willow develops and produces precision fermented functional
ingredients for the health and wellness, food and beverage and
personal care markets. Willow's FutureGrown™ biotechnology
platform allows large-scale production with sustainability at its
core. Willow's R&D team has a proven track record of developing
and commercializing bio-based manufacturing processes and products
to benefit our B2B partners and their customers.
Forward-Looking Statements
This news release may include forward-looking statements
including opinions, assumptions, estimates and the Company's
assessment of future plans and operations, and, more particularly,
statements concerning: development and commercial production of
FutureGrownTM Astaxanthin; potential demand and market
size in respect of Astaxanthin; the continued development of
Willow's FutureGrown™ products, including the ability to obtain all
requisite approvals or certifications; intellectual property
protection; changing consumer sentiments; and the business plan of
the Company generally, including commercial production of
FutureGrownTM Astaxanthin. The company is also making
forward looking statements with respect to the webcast, including
the date and time, speakers and agenda, ability of participants to
utilize the interactive Q&A portal, and the period of time
during which an archived version of the webcast will be available
on the Company's website. When used in this news release, the words
"will," "anticipate," "believe," "estimate," "expect," "intent,"
"may," "project," "should," and similar expressions are intended to
be among the statements that identify forward-looking statements.
The forward-looking statements are founded on the basis of
expectations and assumptions made by the Company which include, but
are not limited to: the success of Willow's strategic partnerships,
including the development of future strategic partnerships; the
financial strength of the Company; the ability of the Company to
fund its business plan using cash on hand and existing resources;
changes in the market and consumer demand for Willow's products,
including FutureGrownTM Astaxanthin; the ability of the
Company to obtain and retain applicable licences; the ability of
the Company to obtain suitable manufacturing partners and other
strategic relationships; and the successful implementation of
Willow's commercialization and production strategy generally.
Forward-looking statements are subject to a wide range of risks and
uncertainties, and although the Company believes that the
expectations represented by such forward-looking statements are
reasonable, there can be no assurance that such expectations will
be realized. Any number of important factors could cause actual
results to differ from the Company's expectations, including but
not limited to: changes in the biotechnology industry generally;
the success of the Company's research and development strategies;
risks related to intellectual property, including infringement;
failure to benefit from partnerships or successfully integrate
acquisitions; actions and initiatives of federal and provincial
governments and changes to laws, regulations, and government
policies and the execution and impacts of these actions,
initiatives and policies; import/export and research restrictions
for cannabinoid-based operations; competition from other industry
participants; adverse U.S., Canadian and global economic
conditions; adverse global events and public-health crises,
including the current COVID-19 outbreak; failure to comply with
certain regulations; departure of key management personnel or
inability to attract and retain talent; and other factors more
fully described from time to time in the reports and filings made
by the Company with securities regulatory authorities. Please refer
to the Company's most recent annual information form and
management's discussion and analysis for additional risk factors
relating to Willow, which can be accessed either on Willow's
website at www.willowbio.com or under the Company's profile on
www.sedar.com. The forward-looking statements contained in this
news release reflect management's expectations only as of the date
hereof and readers are cautioned not to place undue reliance
on any such forward-looking statements. The Company does not
undertake any obligation to update publicly or to revise any of the
included forward-looking statements, except as required by
applicable law. The forward-looking statements contained herein are
expressly qualified by this cautionary statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/willow-biosciences-to-host-investor-presentation-webcast-301669672.html
SOURCE Willow Biosciences Inc.